<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW, NOARCHIVE" />
<meta name="dc.language" content="eng" />
<meta name="dc.title" content="Ledyit v. Bristol-Myers Squibb Canada Inc. (May 12, 2008)" />	
<meta name="dc.date.created" content="2008-05-12" />
<meta name="dc.date.modified" content="2008-05-12" />
<title>Ledyit v. Bristol-Myers Squibb Canada Inc. (May 12, 2008)</title>
<style>
<!--
h1
	{text-align:center;
	page-break-after:avoid;
	font-size:15.0pt;
	font-family:"Times New Roman";
	font-weight:normal;}
h2
	{text-align:center;
	line-height:200%;
	page-break-after:avoid;
	font-size:15.0pt;
	font-family:"Times New Roman";}
h3
	{text-align:justify;
	font-size:13.0pt;
	font-family:"Times New Roman";}
h4
	{text-align:justify;
	line-height:200%;
	page-break-after:avoid;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{text-align:justify;
	tab-stops:center 3.0in right 6.0in;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{text-align:justify;
	tab-stops:center 3.0in right 6.0in;
	font-size:13.0pt;
	font-family:"Times New Roman";}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{text-align:justify;
	font-size:8.0pt;
	font-family:Tahoma;}
p.Doubleindent-quote, li.Doubleindent-quote, div.Doubleindent-quote
	{text-align:justify;
	tab-stops:1.5in;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.DOCKETINFOFIELD, li.DOCKETINFOFIELD, div.DOCKETINFOFIELD
	{text-align:right;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.Double-indent-subquote, li.Double-indent-subquote, div.Double-indent-subquote
	{text-align:justify;
	tab-stops:2.0in;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.headingNUMBER, li.headingNUMBER, div.headingNUMBER
	{text-align:justify;
	text-indent:0in;
	line-height:200%;
	tab-stops:.5in;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.COURTOFAPPEAL, li.COURTOFAPPEAL, div.COURTOFAPPEAL
	{text-align:center;
	font-size:15.0pt;
	font-family:"Times New Roman";}
p.StyleofCause, li.StyleofCause, div.StyleofCause
	{text-align:center;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.ParaNO, li.ParaNO, div.ParaNO
	{text-align:justify;
	line-height:200%;
	tab-stops:.5in;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.RespondentAppellant, li.RespondentAppellant, div.RespondentAppellant
	{text-align:right;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.Versus, li.Versus, div.Versus
	{text-align:center;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.Party, li.Party, div.Party
	{font-size:13.0pt;
	font-family:"Times New Roman";}
p.Panel, li.Panel, div.Panel
	{text-align:center;
	font-size:13.0pt;
	font-family:"Times New \(W1\)";}
ol
	{ul
	{-->
</style>
</head>
<body bgcolor="#FFFFFF" vlink=purple lang=EN-CA>
<div class=Section1>
  <table border=0 align="center" cellpadding=0 cellspacing=10>
    <tr>
      <td width=638 valign=top><p class=DOCKETINFOFIELD>CITATION:&nbsp;Ledyit&nbsp;v.&nbsp;Bristol-Myers
          Squibb Canada Inc.,&nbsp;2008 ONCA 372</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=DOCKETINFOFIELD>DATE: 20080512</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=DOCKETINFOFIELD>DOCKET: C47821</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=COURTOFAPPEAL>COURT OF APPEAL FOR ONTARIO</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Panel>ROSENBERG, LANG and EPSTEIN JJ.A.</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p>BETWEEN:</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=StyleofCause>STEVEN LEDYIT and LOUISE
          LEDYIT</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=RespondentAppellant>Plaintiffs (Respondents/Cross-Appellants)</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Versus>and</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p align=center style='text-align:center'>BRISTOL-MYERS
          SQUIBB CANADA INC., BRISTOL, MYERS SQUIBB COMPANY, LINSON PHARMA INC.,
          APOTEX INC., PHARMEL INC., </p>
        <p align=center style='text-align:center'>DOMINION PHARMACAL, NOVOPHARM
          LIMITED, PHARMASCIENCE </p>
        <p align=center style='text-align:center'>INC., and GENPHARM INC.</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=RespondentAppellant>Defendants (Appellant/Cross-Respondents,
          Apotex Inc.;</p>
        <p class=RespondentAppellant>Novopharm Limited; Bristol-Myers Squibb
          Canada Inc; Genpharm Inc.                   </p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party>Adrian C. Lang for the appellant/cross-respondent,
          Apotex Inc.</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party>Joel P. Rochon for the respondents/cross-appellants</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party>Heard: May 6,
          2008</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party style='text-align:justify'>On appeal
          from the order of Justice Maurice C. Cullity of the Superior Court
          of Justice, dated September 13, 2007.</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party align=center style='text-align:center'>ENDORSEMENT</p></td>
    </tr>
  </table>
  <p class=headingNUMBER style='line-height:normal'>[1]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>The
    appellant, Apotex Inc., challenges the decision of the motion judge, Cullity
    J., to amend the claim by substituting two Québec representative plaintiffs
    in this
    <st1:State w:st="on">
    <st1:place w:st="on">
    Ontario class action.  The challenge is made on the basis that the respondents’ action
    does not have a real and substantial connection to
    <st1:place w:st="on">
    <st1:City w:st="on">
    Ontario,
    <st1:State
 w:st="on">
    Ontario is not the convenient forum and the action is an abuse of process. </p>
  <p class=headingNUMBER style='line-height:normal'>[2]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>We
    agree with the reasons of the motion judge that
    <st1:State
w:st="on">
    Ontario courts have jurisdiction over this action because Apotex Inc. is
    resident in and carries on business in
    <st1:State w:st="on">
    <st1:place
 w:st="on">
    Ontario.  Even if we accept the appellant’s argument that the real and substantial
    connection test must nonetheless be applied, the factors that inform that
    test support the conclusion that Ontario has jurisdiction <i>simpliciter</i> on
    the record in this case.  This is particularly so where the representative
    plaintiffs are prepared to come to the jurisdiction where the defendant resides
    and carries on business.  </p>
  <p class=headingNUMBER style='line-height:normal'>[3]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>In
    addition, we do not accept the appellant’s argument that the motion judge
    ought to have exercised his discretion to find that Québec is the more convenient
    forum, especially in light of the limited material on the motion, which simply
    involved a motion to amend the claim to substitute the representative plaintiffs.  The
    appellant is not precluded from bringing a motion regarding <i>forum non
    conveniens</i> on appropriate material.     </p>
  <p class=headingNUMBER style='line-height:normal'>[4]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>We
    also reject the appellant’s argument that the motion judge erred in accepting
    counsel’s assurance, given as an officer of the court, and subsequently confirmed
    in writing, that the Québec proceedings would not advance pending the certification
    decision in the Ontario proceeding and, if certified, that the Québec action
    would not proceed.  In those circumstances, it cannot be successfully argued
    that the Ontario action is an abuse of process.</p>
  <p class=headingNUMBER style='line-height:normal'>[5]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Although
    this issue was not pursued in oral argument, we also agree with the motion
    judge that it would be premature to make a determination regarding the suitability
    of the representative plaintiffs, particularly in the absence of any evidence
    that the applicable Québec law differs from
    <st1:State w:st="on">
    <st1:place w:st="on">
    Ontario law. </p>
  <p class=headingNUMBER style='line-height:normal'>[6]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Accordingly,
    the appeal is dismissed.  Costs to the respondent in the agreed-upon amount
    of $7,500, plus disbursements and Goods and Services Tax.  We note that the
    cross-appeal was abandoned.</p>
  <p>“M. Rosenberg J.A.”</p>
  <p>“S.E. Lang J.A.”</p>
  <p>“G. Epstein J.A.”</p>
</div>
</body>
</html>
